KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Nu Skin Enterprises (NUS) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Nu Skin Enterprises (NUS) over the last 16 years, with Q4 2025 value amounting to $391.2 million.

  • Nu Skin Enterprises' Accumulated Depreciation & Amortization rose 1084.16% to $391.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $391.2 million, marking a year-over-year increase of 1084.16%. This contributed to the annual value of $391.2 million for FY2025, which is 1084.16% up from last year.
  • Latest data reveals that Nu Skin Enterprises reported Accumulated Depreciation & Amortization of $391.2 million as of Q4 2025, which was up 1084.16% from $353.0 million recorded in Q4 2024.
  • In the past 5 years, Nu Skin Enterprises' Accumulated Depreciation & Amortization registered a high of $391.2 million during Q4 2025, and its lowest value of $342.2 million during Q4 2022.
  • For the 5-year period, Nu Skin Enterprises' Accumulated Depreciation & Amortization averaged around $361.3 million, with its median value being $354.7 million (2023).
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first crashed by 638.89% in 2022, then surged by 1084.16% in 2025.
  • Nu Skin Enterprises' Accumulated Depreciation & Amortization (Quarter) stood at $365.5 million in 2021, then dropped by 6.39% to $342.2 million in 2022, then rose by 3.66% to $354.7 million in 2023, then fell by 0.49% to $353.0 million in 2024, then increased by 10.84% to $391.2 million in 2025.
  • Its Accumulated Depreciation & Amortization stands at $391.2 million for Q4 2025, versus $353.0 million for Q4 2024 and $354.7 million for Q4 2023.